Gaudium IVF And Women Health Limited
ListedMainboardHealthcare · NSE / BSE
Founded in March 2015, Gaudium IVF and Women Health Limited specializes in In Vitro Fertilization (IVF) and women’s healthcare services across India, operating through a hub-and-spoke model with seven hubs and twenty-eight spokes. The company collaborates with Infertility Experts to promote awareness of Assisted Reproductive Technology (ART) and IVF treatments. Serving patients from countries like Canada, the UK, the USA, Kenya, South Africa, and Oman, Gaudium has centres in key cities such as Delhi, Mumbai, Ludhiana, Srinagar, Patna, and Bangalore. It offers advanced fertility treatments including IVF, ICSI, IUI, ovulation induction, and male infertility solutions, along with specialized care for PCOD/PCOS, endometriosis, and high-risk pregnancies.
Price Band
₹75 – ₹79
Issue Size
₹2088.62 L Cr
Lot Size
189 shares
GMP
₹2
-2.5%
Est. Listing
₹77
at current GMP
Subscribed
7.27x
overall
Open
20 Feb 2026
Close
24 Feb 2026
Allotment
25 Feb 2026
Refund
26 Feb 2026
Demat Credit
27 Feb 2026
Listing
27 Feb 2026
Last updated 7 months ago
Overall Subscription
7.27x
Total Demand
QIB Multiplier
1.62x
Institutions & Funds
NII / HNI
14.05x
High Net-Worth
Retail (RII)
7.60x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 4,177,240 | 6,785,478 | 1.62x |
| NIB | 3,132,930 | 44,022,069 | 14.05x |
| HNIs(10L +) | 2,088,620 | 26,555,634 | 12.71x |
| HNIs (2-10L) | 1,044,310 | 17,466,435 | 16.73x |
| RETAIL | 7,310,170 | 55,542,942 | 7.60x |
| Total | 17,753,270 | 150,372,558 | 7.27x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| RETAIL | 38,678 | 240,713 | 6.22x |
| HNIs(10L +) | 789 | 1,984 | 2.51x |
| HNIs (2-10L) | 395 | 6,296 | 15.94x |
| Total Applications | 39,862 | 248,993 | 6.25x |
Day-Wise Subscription Progress
About Gaudium IVF And Women Health Limited Public Issue & Market Profile
Gaudium IVF And Women Health Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹2,08,86,200 Crores. The shares are offered at a price band of ₹75 to ₹79 per equity share on NSE and BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Bidding & Quota Instructions:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 189 shares (approx. ₹14,931 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment Reconciliation Schedule:
Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2026-02-27, while un-allotted funds or UPI block mandates will be released on 2026-02-26.
Frequently Asked Questions
What is the issue size and price band for Gaudium IVF And Women Health Limited IPO?
The Gaudium IVF And Women Health Limited IPO aggregate issue size is ₹2,08,86,200 Crores with an equity price band set at ₹75 to ₹79 per equity share. The retail lot size is 189 shares requiring a minimum capital outlay of approx. ₹14,931.
How can I check Gaudium IVF And Women Health Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. You can track QIB, NII/HNI, and Retail category multiples directly on our dedicated live subscription page.
Where will Gaudium IVF And Women Health Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2026-02-25.